Physical Layer Security with Its Applications in 5GNetworks： A Review

5G network is expected to support massive user connections and exponentially increasing wireless services,which makes network security unprecedentedly important.Unlike traditional security-guaranteeing techniques which rely heavily on cryptographic approaches at upper layers of the protocol stack,physical-layer security(PLS) solutions fully take advantages of the characteristics of wireless channels to degrade the received signal qualities at the malicious users,and realize keyless secure transmission via signal design and signal processing techniques.PLS avoids the difficulties in the distribution and management of secret keys,and provides flexible security levels through adaptive transmission protocol design.Moreover,PLS techniques match the features of 5G networks well.Therefore,the application of PLS to 5G networks is a promising solution to address the security threats.This article presents a comprehensive review of the state-of-the-art PLS techniques,and discusses their applications in 5G networks.We first summarize the principle and advantages of PLS techniques,and point out the reasons why PLS is suitable for 5G networks.Then,we review the existing PLS methods in literature,and highlight severalPLS solutions that are expected to be applied in 5G networks.Finally,we conclude this article and figure out some further research directions.

Imetit Dihydrobromide and Thioperamide Medication in Cough Hypersensitivity Model—The Role of H3 Receptors

Chronic cough is a troublesome problem and it is frequently associated with diseases such as gastroesophageal reflux, asthma and upper airway diseases—so called diagnostic triade. The magnitude and severity of cough is strongly associated with the ongoing nasal inflammation in subjects with rhinosinusitis and treatment of nasal inflammation leads to the down regulation of pathologically up-regulated cough. Histamine plays a key role in the inflammation of the upper airways of different aetiologies;therefore histamine receptors seem to be promising targets. The aim of our study was to ascertain the effect of H3R agonist imetit and H3R antagonist thioperamide on cough and symptoms of allergic rhinitis (AR) in an animal model of upper airway cough syndrome in ovalbumin sensitized guinea pigs. OVA sensitized guinea pigs (n = 10) were repeatedly challenged with i.n. allergen-OVA to induce allergic rhinitis and to enhance cough reflex according to the validated model of experimental allergic rhinitis. Animals were pre-treated by i.p. administration of imetit (1 mg/kg and 2 mg/kg of body weight) and thioperamide 30 min. prior i.n. OVA administration. Rhinitis evaluation was based on the occurrence of typical symptoms. The effect on cough was assessed from the response to inhalation of citric acid (0.4 M, 10 min), final cough count and cough latency were analysed from the airflow traces, cough motor pattern and the cough sound. AR up-regulated the cough response from 9 ± 2 to 16 ± 1 cough per provocation, med ± IQR, p < 0.05 and shortened cough latency. Imetit (1 mg/kg) suppressed nasal symptoms and decreased number of cough from 16 ± 1 to 12 ± 1;however the data did not reach significance. Imetit (2 mg/kg) significantly suppressed the nasal symptoms, and number of coughs from 16 ± 1 to 6 ± 2, med ± IQR, p < 0.05. Thioperamide (5 mg/kg of body weight) did not have expected effects on tested parameters. H3R agonist imetit, unlike H3R antagonist thioperamide has antitussive potential and ability to suppress nasal symptoms in animal model of allergic rhinitis.